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Abstract 
 
Introduction: Emergency workers dedicate their lives to promoting public health and 
safety, yet suffer higher rates of post-traumatic stress disorder (PTSD) and major 
depression (MD) compared to the general population. They also suffer an associated 
increased risk for physical health problems, which may be linked to specific 
immunological and endocrine markers or changes in relevant markers. Poor physical 
and mental health is costly to organisations, the NHS and society.  Existing 
interventions aimed at reducing risk of mental ill health in this population are not 
very successful. More effective preventative interventions are urgently needed. We 
first conducted a large-scale prospective study of newly recruited student 
paramedics, identifying two cognitive factors (rumination and resilience appraisals) 
that predicted episodes of PTSD and MD over a two-year period. We then developed 
internet-delivered cognitive training for resilience (iCT-R), a supported online 
intervention, to modify cognitive predictors. This protocol is for a randomised 
controlled trial to evaluate the efficacy of the resilience intervention. 
Methods and analysis: 570 student paramedics will be recruited from participating 
universities. They will be randomly allocated to iCT-R or to supported online training 
of an alternative, widely available intervention, or to training-as-usual. Follow-up will 
occur after the intervention/standard practice period, and at six, 12 and 24 months. 
Primary outcomes include rates of PTSD and MD and subsydnromal PTSD and MD, 
measured by the Structured Clinical Interview for DSM-V (SCID-5), the Patient-Health 
Questionnaire-9 (PHQ-9) and the Posttraumatic Stress Disorder Checklist for DSM-5 
(PCL-5). Secondary outcomes include measures of resilience, rumination, anxiety, 
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psychological distress, wellbeing, salivary cortisol, plasma levels of C-reactive 
protein, smoking and alcohol use, weight gain, sleep problems, health-related quality 
of life, health resource utilization and productivity.  
Ethics and dissemination:  The Medical Sciences Inter-Divisional Research Ethics 
Committee at the University of Oxford granted approval, reference: R44116/RE001. 
The results will be published in a peer-reviewed journal. Access to raw data and 
participant information will be available only to members of the research team.  
Trial registration number: ISRCTN16493616. 
Keywords: student paramedics, PTSD, depression, resilience, cortisol, CRP 
Strengths and limitations of this study 
• The study is a large, single-blind randomised controlled trial of internet-
delivered cognitive training for resilience (iCT-R). 
• iCT-R will be evaluated in comparison to an existing intervention and 
treatment as usual. 
• Primary outcomes will be assessed by self-report and objective measures.  
• Full outcome blinding is not possible. 
• Smoking and alcohol use will be measured with unpublished self-report tools. 
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Introduction 
 
Emergency workers carry a threefold increase, compared to the general population, 
in risk for major depression (MD) and posttraumatic stress disorder (PTSD), and an 
associated increased risk of poor physical health.[1] To date, interventions aimed at 
reducing risk of ill mental health in this population have been unsuccessful. 
Randomised controlled trials (RCT) found that trauma risk management, a peer 
support system widely available to the police and ambulance services in England; [2] 
critical incident stress debriefing widely used by UK fire-services, [3] and the charity 
Mind’s six-session group-based resilience intervention had no effect on resilience or 
rates of mental ill health [4]. More effective preventative interventions for 
emergency workers are urgently needed. 
 
Established interventions may have been unsuccessful because they fail to target 
predictors of mental ill health and are offered to emergency workers after rather 
than before repeated exposure to the stresses linked to their work. Moreover, 
cognitive strategies that could help them cope with characteristic stressors are not 
included as part of the training.  For example, our and others’ research has 
demonstrated that exposure to trauma or stressful scenarios through imagery 
reduces anxiety for police officers and other at risk populations. [5, 6]  Development 
of more effective interventions requires identification of predictors of mental 
disorders and an understanding of how to modify them.  
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In a series of experimental and prospective studies, we identified two cognitive 
factors that are robust predictors of poor mental health in emergency workers: 
rumination (repetitive negative thinking) and resilience appraisals. Those who 
reported ruminative thoughts during critical incidents were more likely to 
experience poor levels of coping. [7]  Adaptive appraisals during analogue trauma 
led to more successful attempts to regulate emotions and fewer PTSD symptoms. [8]  
Our large-scale prospective study of newly recruited paramedics investigated 
predictors of PTSD and MD derived from cognitive theories of PTSD and depression. 
[1] Rumination at the start of paramedic training uniquely predicted PTSD; low 
resilience uniquely predicted an episode of MD.  
 
We then developed an intervention to modify peri-traumatic ruminative thinking 
(i.e, thinking repetitively in an abstract way during trauma). Training to think in a 
concrete style (e.g., focusing on objective details and the sequence of events) led to 
significantly fewer intrusive memories and PTSD symptoms than individuals trained 
in a ruminative style. [9]  We also applied one of the core techniques of a successful 
treatment for PTSD (cognitive therapy for PTSD,[10]), updating the memory of the 
stressful event with helpful information, as a preventative strategy for dealing with 
analogue trauma and found that it is more helpful in reducing repetitive thinking and 
PTSD symptoms than control interventions including exposure. [11] 
 
Research has further demonstrated that exposure to trauma or stressful scenarios 
through imagery reduces anxiety for police officers and other at risk populations, 
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and that internet-based cognitive treatment that includes attention training as a 
core component significantly reduces anxiety. [5, 6, 12] 
 
Neurobiological Factors linked to PTSD and MD 
Genetic and longitudinal studies suggest that inflammation is a pre-existing 
vulnerability factor for the development of PTSD in trauma-exposed individuals 
rather than simply a correlate of subjective distress, disease severity, or maladaptive 
coping strategies following PTSD onset. [13, 14] For example, brain imaging studies 
have shown that high inflammation levels may increase threat perception (negative 
valence). Peripheral administration of lipopolysaccharides (LPS), residues from 
bacterial cells’ components known to elicit a strong systemic inflammatory response, 
potentiates amygdala activity in response to socially threatening stimuli (fear 
faces).[15] In turn, greater pre-treatment amygdala reactivity to threat predicts less 
symptom reduction during CBT.[16] Additionally, inflammation is an important risk 
factor for depression and cardiovascular disease, which frequently accompany 
PTSD.[17-19] Our study will investigate the link between inflammation and the 
development of PTSD and MD in trauma-exposed student paramedics. We will 
investigate whether or not iCT-R can reduce levels of clinically-relevant inflammation 
levels, such as C-Reactive Protein (CRP), known to increase risk of psychiatric as well 
as cardiovascular and metabolic conditions comorbid with PTSD and MD. 
  
Given the wealth of literature supporting a relationship between the stress 
hormone, cortisol, and PTSD and MD, we will also systematically assess the cortisol 
awakening response (CAR) and diurnal cycle. The CAR is an endocrine marker, 
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defined as the change in cortisol concentration that occurs during the first hour after 
waking from sleep.[20] A meta-analysis of 62 studies concluded that increases in the 
CAR were associated with job stress and life stress and linked to greater fatigue, 
burnout and exhaustion and risk for later health states, such as coronary heart 
disease.[21] A recent study found that higher CAR predicted future episodes of MD 
within a 2.5-year period.[20] We anticipate that iCT-R will reduce the CAR and 
cortisol throughout the day and protect against the development of PTSD and MD. 
 
Study Objectives 
The primary aim of the study is to evaluate the efficacy of internet cognitive training 
for resilience (iCT-R).  We hypothesise that iCT-R will lead to fewer cases of PTSD and 
major depression (including subsyndromal PTSD and MD) and less severe PTSD and 
MD symptomatology at follow-up compared to an existing online training (Mind-
Online) and standard practice.   
 
Secondary Objectives 
We hypothesise that iCT-R will lead to greater improvement in secondary outcome 
measures (resilience, rumination, hormone and immune function, smoking, weight 
gain, alcohol use, symptoms of anxiety, and sleep problems, psychological distress, 
wellbeing) than Mind-Online and standard practice.  We also expect that iCT-R will 
be more cost-effective than Mind-Online and standard practice because of lower 
cost per participant without an episode or with low symptoms of PTSD or MD and 
lower costs per quality adjusted life years (QALY) gained for participants receiving 
iCT-R. 
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Tertiary Objectives 
We want to establish which baseline factors influence the effect of the interventions 
on primary and secondary outcomes so that we may make inferences about  
mechanisms of intervention efficacy. Understanding the effects that modifying risk 
and protective factors have may drive the refinement of future interventions. Our 
tertiary objectives are to determine which psychiatric, personality, trauma and social 
support factors at baseline (social support, trauma exposure, anxiety, age, gender, 
education, neuroticism, past and current psychiatric status, immune function) may 
influence (i.e., moderate) the effect of the interventions on levels of symptoms 
(PTSD or MD), psychological distress and wellbeing at follow-up.  Determining which 
factors moderate outcome may inform improvements to the intervention.  For 
example, should baseline factors, such as education or age moderate outcome, then 
the intervention could be improved in light of relevant moderators.  This could 
include making it more accessible to younger participants with less education should 
this be relevant, for example.  We will also investigate whether or not changes in 
resilience-related factors (rumination, responses to intrusions, concrete thinking, 
resilience appraisals, practice of iCT-R/Mind-Online tools) mediate symptom levels of 
PTSD and MD at one and two-year follow-up with iCT-R and Mind-Online.  Finally, we 
will investigate whether or not concrete thinking, practice of tools and responses to 
intrusions at 6 months predict diagnoses and levels of PTSD and depression 
symptoms at one and two-year follow-up.   
 
Methods 
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The protocol includes all details required for the World Health Organization Trial 
Registration Data Set (Appendix 1) and was written in line with the SPIRIT Statement, 
which outlines recommendations for a minimum set of scientific, ethical, and 
administrative elements that should be addressed in a clinical trial (Appendix 2).[22]   
 
Design 
The proposed study is a single-blind (assessors blinded) randomised controlled trial 
in which N=570 student paramedics will be randomly allocated to receive internet-
delivered cognitive training for resilience (iCT-R), an already available intervention 
(Mind Online) that has been investigated in previous trials or standard practice. 
Participants are also invited to give salivary and plasma samples before and after the 
interventions and at one and two-year follow-up. The trial will take place from 
October 2017 to January 2021. 
 
Participants 
Student paramedics will be recruited from collaborating paramedic training 
programmes (University of Brighton, Oxford Brookes University, Bournemouth 
University, University of Hertfordshire, University of Worcester, University of Surrey 
and Anglia Ruskin University). The locations selected constitute rural and city 
locations to improve generalisability. The researchers will present the study to each 
year group at collaborating universities to ensure the maximum reach of 
recruitment. After presenting the study, researchers will collect names and email 
addresses of interested students and email the registration survey including the 
participant information sheet (Appendix 3).  
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Inclusion and Exclusion Criteria 
Students who are aged 18 and above, are training to be paramedics, and are in years 
1, 2 or 3 of their paramedic training programme will be eligible for the study. They 
will be screened for levels of PTSD and MD, and a trained research assistant will 
contact participants if they score in the clinical range on measures of PTSD or MD, or 
report suicidal ideation to evaluate whether they are eligible or need treatment 
(under JW’s supervision). The screening survey will trigger automatic notifications to 
the research assistant and the principal investigator if a participant scores 10 or 
above on the Patient Health Questionnaire 9 (PHQ-9)[23] or 1 or above on the 
suicidal ideation item of the same questionnaire or 33 or above on the Posttraumatic 
Stress Disorder Checklist for DSM-5 (PCL-5) [24]. Participants will be excluded from 
the study if their symptoms are interfering with their lives and they would like 
treatment, and the research assistant will offer them information on how to access 
evidence-based treatment for these conditions in local services.  
 
Sample Size Calculation 
The risk of student paramedics developing full syndromal PTSD and MD over two 
years without intervention is 10%, and 25% if subsyndromal PTSD and MD are 
included [1]. Since there are no interventions for emergency workers which target 
modifiable risk factors, we referred to a study with a similar approach to facilitate 
the calculation of power.  Topper at al. (2017) evaluated the effects of an 
intervention targeting rumination on rates of depression in adolescents at one year 
follow-up in comparison to a waitlist condition.[25]  The intervention reduced the 
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rates of depression by 67% in comparison to the wait list condition.  We estimated 
that our intervention, which also aims to modify rumination, would reduce rates of 
PTSD and depression by 50% in comparison to an existing intervention which has 
shown no change in rates of PTSD or MD over time. [4]	Setting power at 80%, α=.05 
and hypothesizing a reduction of relative risk of 50% gives an odds ratio of 0.429, 
which requires a total sample size of N=304 to show a risk reduction of 50% between 
iCT-R and the alternative intervention. Thus, each condition would require N=152. 
Since we have a third condition (standard practice), the total sample size required 
would be N=456. Allowing for a 20% rate of attrition, we will require a total sample 
size of N=570. 
 
Randomisation and blinding 
Participants will be randomised on a 1:1:1 ratio as per a computer-generated 
randomisation schedule stratified by site, gender and baseline PHQ-9 score (≥9 
versus <9) and PCL-5 score (≥33 versus <33). The Oxford Clinical Trials Research Unit 
is independent to the research team and developed the randomisation programme. 
The researchers will inform participants of the intervention they are to receive after 
they have completed baseline assessments. Outcome assessment will be single 
blind; questionnaires are completed online without any involvement of the 
researchers, the clinical interview will be conducted by an independent assessor 
blind to treatment allocation, and all personnel involved in processing and assessing 
the blood and saliva samples will be blinded to treatment allocation. Due to the 
nature of the interventions, participants cannot be completely blinded to allocation. 
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However, the inclusion of an already available, alternative intervention aims to 
mitigate some risk of bias. 
 
Intervention arms 
Internet-delivered cognitive training for resilience (iCT-R) 
iCT-R aims to modify rumination and appraisals linked to low resilience in a six-
session supported online intervention. We include an imagery component, practice 
of strategies that been shown to prevent stress-related responses from 
developing,[8, 9] attention training,[12] and monthly top up exercises during follow-
up to consolidate training, an approach that is lacking with existing interventions.  
 
Our intervention follows a similar format to the internet-based programmes Clark, 
Ehlers, Wild and colleagues have developed for social anxiety and PTSD [12, 26]. The 
core information is delivered in six modules. The modules include whiteboard videos 
to explain concepts, audio files for practicing concrete thinking, testimonies from 
qualified paramedics and video footage of student paramedic call-outs for use in 
experiential exercises. Following our findings of the protective benefits of concrete 
thinking [8] and the wealth of work in this area [i.e., 27] participants are regularly 
reminded to practise concrete thinking. 
 
The modules are: 
1. It Matters What you Focus On: Helpful and Unhelpful Attention 
2. Get Out of Your Head with Helpful Thinking 
3. Habits and Dwelling: How to Change Them 
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4. Dealing with Unwanted Memories: Then vs Now 
5. Transforming Worries & Improving Performance 
6. Beating Stress & Trauma: My Blueprint 
 
A trained online coach (research assistant) provides email feedback on students’ 
responses and, through an automated SMS programme, sends regular brief 
reminders of key points and notifications to practice IF-THEN plans (a technique 
shown to help individuals respond to warning signs for stress and dwelling).  
 
Mind Online 
The alternative intervention is a series of six modules available online covering 
information and advice about stress, sleep problems, anger, depression, PTSD and 
mindfulness. Participants will receive the same frequency, type and duration of 
remote support as in iCT-R. 
 
Standard Practice 
The third condition is training as usual. Participants will have access to the usual 
support offered through their university but they will not receive any online modules 
or remote support. They will be offered the iCT-R at the end of follow-up, when the 
study is completed. 
 
Primary Outcome Measures 
Levels of PTSD and MD 
An independent assessor will administer the PTSD and MD modules of the 
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Structured Clinical Interview for DSM-5 (SCID-5) to assess clinical and subsyndromal 
PTSD and MD [28]. The SCID-5 is an interview schedule for determining DSM-5 
psychiatric diagnoses. PTSD and MD symptomatology will also be assessed with 
continuous measures:  the PCL-5 and the PHQ-9 [24, 23], which will be completed at 
screening, which is typically the same day or shortly before the baseline 
questionnaires are released and completed.  The PHQ-9 and PCL-5 scores at 
screening will be used as baseline scores in analyses. The PCL-5 is a self-report 
measure consisting of 20 questions that parallel the diagnostic criteria for PTSD set 
out in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition [29]. 
Items are scored on a 5-point Likert scale (0 = “Not at all” to 4 = “Extremely”). The 
PHQ-9 is a well-validated 9-item self-report measure that assesses symptoms of 
depression. Items are scored on a 4-point Likert scale (0 = “Not at all” to 3 = “Nearly 
every day”). See Table 1 for the full list of outcomes, measures and assessment time 
points. 
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Table 1. Outcomes and measures 
 Domain Measures Time 
point* 
Primary 
Outcomes 
PTSD Structured Clinical Interview for DSM-5 Disorders (SCID-5).[28] 
Post-traumatic Stress Disorder Checklist (PCL-5).[24] 
0 1 3 4 
0 1 2 3 4 
 MD Structured Clinical Interview for DSM-V Disorders (SCID-5).[28]. 
Patient Health Questionnaire 9 (PHQ-9).[23] 
0 1 3 4 
0 1 2 3 4 
Secondary 
Outcomes 
Resilience Connor-Davidson Resilience Questionnaire (CD-RISC).[30] 
Wagnild Resilience Scale.[31] 
0 1 3 4 
0 1 3 4 
 Rumination Ruminative Responses Scale (RRS) brooding subscale.[32] 
Responses to Intrusions Questionnaire (RIQ) dwelling subscale.[33] 
0 1 3 4 
 Anxiety 
 
Generalized Anxiety Disorder 7-item scale (GAD-7).[34] 0 1 3 4 
 Smoking and 
Alcohol use 
Smoking Behaviour Questionnaire.[1] 
Alcohol Use Questionnaire.[1] 
0 1 3 4 
 Weight and 
Height 
Questionnaire recording participants’ height and weight.[1] 0 1 3 4 
 Psychological 
distress 
General Health Questionnaire (GHQ-12).[35] 0 1 3 4 
 Wellbeing 
 
Warwick Edinburgh Mental Wellbeing Scale (WEMWBS).[36] 0 1 3 4 
 Hormone 
function 
Level of cortisol in response to awakening and throughout the day. 0 1 3 4 
 Immune 
function 
Level of C-reactive protein. 0 1 3 4 
 Sleep problems 
 
Insomnia Severity Index (ISI)[37] 0 1 3 4 
 Health 
economics  
EuroQol (EQ-5D-5L).[38] 
Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness 
(TiC-P).[39] 
Client Service Receipt Inventory.[40] 
Health and Labor Questionnaire [41] 
0 1 3 4 
0 1 3 4 
 
0 1 3 4 
0 1 3 4 
Tertiary 
Outcomes 
Neuroticism Eysenck Personality Questionnaire (EPQ) neuroticism subscale.[42] 0 1 3 4 
 Social support Social Support scale (SS) adapted from a brief measure of social 
support.[43] 
0 1 3 4 
 Demographics  
 
General information questionnaire.[1] 0 1 3 4 
 Trauma 
exposure 
Trauma Screener.[44] 0 1 2 3 4 
 Concrete 
thinking 
Concrete thinking questionnaire, adapted from a previous concrete 
thinking assessment.[45] 
0 1 2 3 4 
 Intrusions Duration, frequency and distress linked to Intrusions Questionnaire.[46] 
 
0 1 2 3 4 
*Timepoint: 0 = baseline, 1 = post-intervention, 2 = 6 month follow-up, 3 = 12 month follow-up, 4 = 24 
month follow-up 
 
Secondary Outcomes 
Psychological outcomes 
Two measures of resilience will be administered:  the Wagnild Resilience Scale and 
the Connor-Davidson Resilience Questionnaire (CD-RISC). [31, 30] Two measures of 
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resilience will be used since it is unclear which one most sensitively measures 
resilience in student paramedics. The Wagnild Resilience Scale is a 25-item scale that 
measures resilience by rating responses to statements on a 7-point Likert scale (0 = 
“Strongly disagree” to 7 = “Strongly agree”). The CD-RISC is a commonly used self-
report measure of resilience with 25 items scored on a 5-point Likert scale (0 = “Not 
true at all” to 4 = “True nearly all the time”). Both scales are well-validated measures 
with excellent psychometric properties. Rumination will be assessed with the 
brooding subscale of the Ruminative Responses Scale (RRS), a reliable and valid 
measure of the frequency of engaging in dwelling [32].  Rumination in response to 
unwanted memories will be assessed with the dwelling subscale of the Responses to 
Intrusions Questionnaire (RIQ), a reliable and valid measure of maladaptive 
responses to intrusive memories [33]. Anxiety will be measured with the Generalized 
Anxiety Disorder scale 7 (GAD-7), a 7-item scale with items scored on a 4-point Likert 
scale (0 = “Not at all” to 3 = “Nearly every day”) [34].  Psychological distress will be 
measured with the reliable and valid 12-item General Health Questionnaire 12 
(GHQ-12) [35].  Wellbeing will be assessed using the Warwick Edinburgh Mental 
Wellbeing Scale (WEMWBS) [36]. The WEMWBS has 14 items and is scored on a 5-
point Likert scale (1= “None of the time” to 5 = “All of the time”).  
 
Hormone and immune function 
Salivary cortisol will be assessed by RIA assay analysis. A sample of saliva will be 
collected upon awakening, 15, 30 and 60 minutes after awakening, and at 12 noon 
and 8pm.  Baseline high-sensitive CRP plasma levels will be measured using an ILab 
600 spectrophotometric method in serum samples. 
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Health outcomes 
Smoking and alcohol use will be measured with unpublished questionnaires since 
two of our assessment points (1 and 2 year follow-up) require participants to report 
current use as well as changes in alcohol use and smoking over the previous year, a 
time period not currently referenced in validated tools.  Shorter questionnaires may 
reduce response burden and improve questionnaire completion.  Participants will be 
asked to indicate whether or not they smoke, how many cigarettes they smoke a 
day, and whether this has increased, decreased, or stayed the same in the last year. 
They will also be asked how many units of alcohol they have had in the last week, 
whether this is an average amount for them, and if not, how many units they usually 
drink per week. Weight gain will be measured by increases in BMI. Participants will 
be asked to provide their weight and height. The researchers will take weighing 
scales and a tape measure to study visits to weigh and measure participants. Sleep 
problems will be assessed by the Insomnia Severity Index (ISI), which is a reliable and 
valid brief self-report instrument of sleep quality and sleep difficulties.[37]  In line 
with NICE guidelines, health related quality of life will be measured by the five-levels 
version of the EuroQol 5 Dimensions questionnaire (EQ-5D-5L).[38] The EQ-5D-5L is 
a validated and widely used generic measurement of health related quality of life 
based on five dimensions: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Although, we do not expect that all five dimensions will be 
affected by the intervention, we need to collect data on all dimensions in order to 
determine quality adjusted life years (QALYs). 
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Costs 
The economic evaluation will be conducted by taking the NHS perspective (including 
the costs of using mental health services) and the broader societal perspective 
(including the costs of productivity loss due to illness). Mental health resource 
utilisation will be measured with an adapted version of the Clinical Service Receipt 
Inventory (CSRI) and valued by using published unit costs (e.g. NHS Reference Costs 
and Unit Costs of Health and Social Care).[40]. Productivity loss will be measured 
with Short Form-Health and Labor Questionnaire (SF-HLQ),[41] a validated 
questionnaire part of the Trimbos/iMTA questionnaire for Costs associated with 
Psychiatric Illness (TiC-P).[39] 
 
Tertiary Outcomes 
To assess potential moderators of outcomes, we will measure psychiatric, 
personality, trauma and social support factors at baseline (social support, trauma 
exposure, anxiety, age, gender, education, neuroticism, past and current psychiatric 
status, immune function).  The neuroticism subscale (12 items) of the Eysenck 
Personality Questionnaire (EPQ) has excellent psychometric properties and is a 
measure of emotionality [42]. We will use an adapted version of a brief measure of 
social support (SS), to assess perceived support from and closeness to friends, family 
and work colleagues, as well as use of social support [43]. Trauma exposure will be 
measured using a 19-item unpublished trauma questionnaire relevant to emergency 
workers, which includes items from the Life Events Checklist [44]. We will also collect 
demographic information (age, gender, and level of education), information on the 
duration, frequency and distress linked to the Intrusions Questionnaire [46], and 
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questions about concrete and abstract thinking based on an existing assessment tool 
[45]. Participants will be asked to think about a problem they are having and write 
questions that may go through their minds in relation to the problem. They will then 
be presented with four problem scenarios and asked to select from a list the likely 
thoughts they would have if faced with the problem. The list consists of a range of 
concrete and abstract thoughts. We will investigate whether or not changes in 
resilience-related factors (rumination, responses to intrusions, concrete thinking, 
resilience appraisals, practice of iCT-R/Mind-Online tools) mediate symptom levels of 
PTSD and MD at one and two-year follow-up with iCT-R and Mind-Online.  We will 
also investigate whether or not concrete thinking, practice of tools and responses to 
intrusions at 6 months predict diagnoses and levels of PTSD and depression 
symptoms at one and two-year follow-up.   
Patient and Public Involvement 
We held three User Advisory Groups with student paramedics who contributed to 
the design of the study, the selection of questionnaires, and the content of the 
intervention.  The first User Advisory Group was co-organised with the Research 
Design Service South Central Patient and Public Involvement Officer, Megan Barlow-
Pay.  Research questions and outcome measures were discussed with all feedback 
incorporated, including the development of a module participants requested to 
address socially anxious concerns common to their combined role as student and 
paramedic.  A further two User Advisory Groups were held to review the 
intervention and to develop four versions of a questionnaire to assess concrete and 
abstract thinking in situations specific to student paramedics.  Participants also 
completed the baseline questionnaires to assess their length of time and to provide 
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feedback on the feasibility of administration.  Participants were not involved in the 
recruitment and conduct of the study.  Results will be made available in summary 
format to all participants by email once the study is completed.   
 
Procedure 
Researchers will present the study at collaborating universities and invite student 
paramedics to take part. Interested participants will be given a weblink to the study 
via our software platform, Qualtrics, where they can read and print a PDF copy of 
the Participant Information Sheet and discuss questions with the research assistant 
over the telephone. If they decide to take part, they will be emailed a link where 
they can login, re-read the Participant Information Sheet and complete a consent 
form (see Appendix 3 for the Participant Information Sheet and Consent Form). 
Written consent will be requested from participants before blood and saliva samples 
are taken. It will be made clear that participation is entirely voluntary and that 
volunteers may withdraw from the study at any point without incurring any negative 
consequences.  
 
Participants will be recruited over a 12 month period.  They will complete online two 
questionnaires (PCL-5 and PHQ-9) to assess eligibility. If participants score ≥10 on 
the PHQ-9, ≥33 on the PCL-5 or ≥1 on the PHQ-9 suicidal ideation item, a researcher 
will telephone the participant to determine symptom severity and whether 
treatment is necessary. A risk assessment will be conducted if a participant scores ≥1 
on the PHQ-9 suicidal ideation item. If treatment is needed, participants will be 
signposted to their GP and local psychological services. If participants are eligible and 
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consent to participate in the study, they will be assigned a participant ID number to 
ensure anonymity is maintained. They will complete a set of questionnaires online, 
take part in a clinical interview conducted by an independent assessor, and provide 
blood and saliva samples. The clinical interviews will be recorded on SanDisk MP3 
recorders to ensure that the questions asked are standardised across all assessment 
interviews. Qualified phlebotomists will visit students at their universities to collect 
blood samples. During this study visit, participants will be provided with equipment 
to collect their saliva at home upon awakening and through the day (6 samples in 
total). Saliva and blood samples will be transported to the University of Surrey for 
assay analysis. The blood samples will be centrifuged immediately and only serum 
will be kept for analysis. 
 
Once baseline assessments are completed, participants will be randomly allocated to 
iCT-R, Mind-Online or standard practice.  When the interventions or standard 
practice are completed, participants will complete the full battery of assessments 
again; they will complete the questionnaires online, take part in a clinical interview, 
and provide blood and saliva samples. Six months later, they will complete online a 
shorter set of questionnaires. At 12 and 24-month follow-up, they will complete the 
full battery of assessments again. See Figure 1 for a timeline of the study including 
the enrolment process, randomisation, interventions and assessments. We are 
aware that there are various tasks to complete at each assessment point. This may 
be offputting to participants and increase the likelihood of drop outs and respondent 
fatigue. We will clearly communicate the value of the assessments being 
administered, and participants will be compensated with £30 and a certificate of 
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completion at follow up time points to discourage drop out.  The reasons for non-
adherence to the intervention or dropping out of the study will be recorded. An 
independent rater will assess treatment fidelity. The content of a random sample of 
email communications will be scored for reference to content relevant to each 
training programme. 
 
Insert Fig 1. Study timeline. 
 
Data Management 
Registration and assessment data will be captured online via Qualtrics software. 
Participants will be assigned a unique code to be used for all data files and audio 
tapes. Access to the system will be restricted to named study personnel and via 
password protection. The University of Oxford’s IT services have arranged for the 
files to be encrypted and backed up on a weekly basis using a Tivoli Storage Manager 
(TSM). The data will be copied to three separate tapes; one copy will reside in the 
Tape Robot in the IT Services Machine room and the other two are held in locked 
fireproof safes, one onsite at IT services and one offsite in locked premises. The data 
on the tapes are inaccessible without the TSM database. The data on the offsite 
tapes are encrypted. Papers from clinical interviews will be kept in locked cabinets at 
the University of Oxford. The audiotapes from clinical interviews will be backed up 
online with password-protection and access restricted to study personnel. The blood 
samples will be centrifuged as soon as the laboratory at the University of Surrey 
receives them on the day of collection. The  cellular component will be discarded 
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and the serum will be stored at -80 °C. Saliva samples will be analysed at the 
University of Surrey by RIA assay analysis to detect levels of cortisol.  
 
In line with the Oxford Clinical Trials Research Unit and the Medicines for Human 
Use Clinical Trials Regulations (2004), we have not recruited a Data Monitoring 
Committee (DMC) because recruitment and follow-up occur over a short period, 
there are minimal risks to participants and the trial protocol will not be modified 
regardless of the interim data.   
 
Statistical Analyses 
In line with the BMJ and Consort guidelines, data analysis will be intent-to-treat. All 
participants who have been randomised will be included in analyses, including those 
who drop out. We will compare dichotomous measures (rates of PTSD and MD, 
changes in alcohol use and smoking)  between conditions using Chi square analysis. 
Continuous measures will be analysed using hierarchical linear modelling. This 
analysis models random slopes and intercepts for participants, and tests the fixed 
effects of repeated assessments over time (level 1, pre-intervention, post-
intervention, 1 and 2 year follow-up) and training condition (level 2, iCT-R, Mind-
Online, Standard Practice) using data from all participants. It takes into account that 
participants are nested within site (level 3). Variables will be centred for the analysis. 
The effects of potential moderators (social support, exposure to critical incidents, 
etc.) on PTSD and depression symptoms will be explored by including main effects 
and interactions with treatment effects into the model. Non-significant moderators 
will be removed from the final model.   
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To address the potential for Type I error when evaluating our secondary outcomes 
(i.e., resilience, rumination, hormone and immune function, smoking, weight gain, 
alcohol use, anxiety, sleep problems, psychological distress, wellbeing), we will 
examine and report effect sizes.  Effect sizes are a reliable method for determining 
the quality of the result that do not rely on p-value significance and are not affected 
by the number of outcomes. 
 
Mediation analyses will be conducted to assess whether or not changes in resilience-
related factors (rumination, responses to intrusions, concrete thinking, resilience 
appraisals, practice of iCT-R/Mind-Online tools) and compliance with the training 
programmes mediate symptom levels of PTSD and MD at one and two-year follow-
up with iCT-R and Mind-Online.   
A trial-based economic evaluation will be conducted to investigate the cost-
effectiveness of the intervention in terms of cost per QALY gained.  Uncertainty in 
the results will be addressed in sensitivity analyses and displayed in cost-
effectiveness planes and cost-effectiveness acceptability curves. 
 
Adverse Events  
We do not anticipate any adverse events. However, it is possible that a participant 
may evidence risk at one of the assessment points (pre-intervention, post-
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intervention, or 12 and 24-month follow-up). If this is the case, risk will be assessed 
over the telephone and the individual will be signposted to the appropriate service.  
 
Should a serious adverse event (SAE) occur where, in the opinion of the Principal 
Investigator, the event was ‘related’ (resulted from administration of any of the 
research procedures) and ‘unexpected’ in relation to those procedures, it will be 
reported to the Research Ethics Committee.  Reports of related and unexpected 
SAEs will be submitted within 15 working days of the Principal Investigator becoming 
aware of the event, using the Health Research Authority safety report form for a 
non-Clinical Trial of an Investigation of a Medicinal Product (non-CTIMP). 
 
The University of Oxford has a specialist insurance policy in place, which would 
operate in the event of any participant suffering harm as a result of their 
involvement in the research (Newline Underwriting Management Ltd, at Lloyd’s of 
London).  
 
 
ETHICS AND DISSEMINATION 
 
Ethical approval of the research protocol was gained from The Medical Sciences 
Inter-Divisional Research Ethics Committee at the University of Oxford, 17/08/2017, 
ref: R44116/RE001. This is protocol version 1. Any substantive amendments to the 
protocol will be conducted by the Principal Investigator and reviewed by the 
Research Ethics Committee. 
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The research results will be submitted for publication in a peer-reviewed journal and 
presented at relevant conferences. Direct access to data will be granted to 
authorised representatives from the host institution and the regulatory authorities 
to permit trial-related monitoring, audits and inspections. 
 
Committees. We have established a Trial Oversight Committee (TOC). Our 
independent chairman is Dr Susan Dutton, the Senior Medical Statistician and Oxford 
Clinical Trials Research Unit Lead Statistician. The Principal Investigator is also a 
member of the TOC and we have one lay qualified paramedic member (Graham 
Harris). The TOC will meet before the start of the trial and three more times before 
the end of the trial. 
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FIGURE LEGENDS 
 
Figure 1. Study timeline. The flowchart shows how participants will progress 
through the study from the initial stage of enrolment through to analysis. 
 
 
 
